Medtronic Work in process increased by 3.5% to $883.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.9%, from $782.00M to $883.00M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 5.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $602.00M | $622.00M | $687.00M | $682.00M | $739.00M | $769.00M | $797.00M | $789.00M | $816.00M | $833.00M | $788.00M | $642.00M | $696.00M | $728.00M | $782.00M | $744.00M | $792.00M | $853.00M | $883.00M |
| QoQ Change | — | +3.3% | +10.5% | -0.7% | +8.4% | +4.1% | +3.6% | -1.0% | +3.4% | +2.1% | -5.4% | -18.5% | +8.4% | +4.6% | +7.4% | -4.9% | +6.5% | +7.7% | +3.5% |
| YoY Change | — | — | — | — | +22.8% | +23.6% | +16.0% | +15.7% | +10.4% | +8.3% | -1.1% | -18.6% | -14.7% | -12.6% | -0.8% | +15.9% | +13.8% | +17.2% | +12.9% |
| % of Inventories | 14.0% | 14.3% | 15.2% | 14.8% | 15.4% | 15.2% | 14.8% | 14.9% | 14.4% | 14.5% | 13.8% | 12.3% | 12.9% | 13.3% | 13.9% | 13.6% | 13.5% | 13.9% | 14.0% |
| Share Change | — | +0.3pp | +0.9pp | -0.4pp | +0.6pp | -0.2pp | -0.4pp | +0.1pp | -0.5pp | +0.1pp | -0.7pp | -1.5pp | +0.5pp | +0.4pp | +0.7pp | -0.4pp | -0.1pp | +0.4pp | +0.1pp |